The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

NCT00195715 ·Status: COMPLETED ·Phase: PHASE3

Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon

NCT00348283 ·Status: COMPLETED ·Phase: PHASE3

Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease

NCT04305535 ·Status: UNKNOWN ·Phase: NA

A Study of Abatacept in Patients With Active Crohn's Disease

NCT00406653 ·Status: TERMINATED ·Phase: PHASE3

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00055523 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02499783 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions

NCT03017014 ·Status: TERMINATED

Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients

NCT03172377 ·Status: UNKNOWN ·Phase: PHASE4

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease

NCT02065570 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

NCT00409682 ·Status: COMPLETED ·Phase: PHASE3

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00105300 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02015793 ·Status: COMPLETED ·Phase: PHASE2

Control Crohn Safe Trial

NCT03917303 ·Status: RECRUITING ·Phase: PHASE4

Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

NCT02450513 ·Status: COMPLETED

Adalimumab-psoriasis and Small Bowel Lesions

NCT01556672 ·Status: COMPLETED ·Phase: PHASE4

Special Investigation in Patients With Crohn's Disease (All Patients Investigation)

NCT01298648 ·Status: COMPLETED

A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease

NCT00445939 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease

NCT00445432 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

NCT01235689 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

NCT04102111 ·Status: TERMINATED ·Phase: PHASE2

A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease

NCT01958827 ·Status: COMPLETED ·Phase: PHASE3

Chondroitin Sulfate for Crohn's Disease

NCT01245088 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Exploring the Effects of Vitamin D Supplementation on the Chronic Course of Patients With Crohn's Disease With Vitamin D Deficiency

NCT04308850 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease

NCT04135027 ·Status: UNKNOWN

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

NCT03599622 ·Status: TERMINATED ·Phase: PHASE2